Triterras will not challenge Nasdaq's decision to delist the company's securities because of the timing of the annual report disclosure. Triterras' common stock and warrants will be delisted from Nasdaq 10 days after the release of Form 25, unless the SEC sets a later deadline. The company will then apply to re-list the securities on Nasdaq. Triterras is als...

Triterras' IFRS net profit for 2021 financial year was $45.253 million, up 3.3 times from $13.58 million in the previous year. Revenue increased 3.3 times to $55.474 million compared to $16.898 million a year earlier.

Nasdaq denied Triterras' December 16, 2021 complaint against the Listing Commission's decision to delist the company's common stock and warrants because Triterras has not yet disclosed its annual report on Form 20-F for the fiscal year ended February 28, 2021. Trading of the securities has been suspended since Feb. 3, 2022. Triterras intends to appeal the de...

An Appeals Committee of the Nasdaq Exchange will consider suspending trading of Triterras common stock, followed by a delisting, on January 20, 2022. The fintech company has not disclosed a report on Form 20-F for the fiscal year ended February 28, 2021.